Dear colleagues,
As members of the International Academy of Young Cardiologists (IAYC), our mission is to provide young cardiologists with a unique opportunity to review the latest developments in the field of heart diseases and present their work on an international platform. We are honored to announce that the 5th IAYC Congress will be held in Northern Cyprus between 18-22 September 2024.
This year, we will organize a congress concept with the theme of "Heart Failure". Heart failure is among the leading health problems in terms of mortality and morbidity all over the world.
In this congress, the subject of heart failure will be evaluated in its various aspects in the light of current literature. Abstract sessions will constitute another main part of our congress. Our main concern has been to provide young cardiologists with the opportunity to present their research. Abstracts will be evaluated by our referees and qualified ones will be presented in the sessions. This year, for the first time, the Cardiovascular Academy Congress & IYAC congress will hold joint sessions and meetings with wide participation.
We would like to host you in Cyprus at our scientifically and socially packed congress, where you will be together with your colleagues from all over the world.
Get ready to join us in September!
President of CVA Association
Prof. Dr. Ömer Kozan
General Secretary
Prof. Dr. Mehdi Zoghi
Congress President
Prof. Dr. Berkay Ekici
IAYC Coordinator
Assoc. Prof. Dr. Sinem Çakal
Scientific Program President
Prof. Dr. Arash Hashemi
09:00 - 09:30 |
Congress Opening Speeches
Ömer Kozan (President of CVA Association ) Mehdi Zoghi (General Secretary) Berkay Ekici (Congress President) Sinem Çakal (IAYC Coordinator) Arash Hashemi (Scientific Program President) |
09:30 - 10:45 |
Abstract Session 1
Chairpersons: Selçuk Öztürk, İlaha Aghaeva |
10:45 - 11:00 | COFFEE BREAK (E-POSTER PRESENTATION) |
11:00 - 12:15 |
Abstract Session 2
Chairperson: Sinem Çakal |
12:15 - 14:00 | LUNCH |
14:00 - 15:15 |
Abstract Session 3
Chairperson: M. Raşit Sayın |
15:15 - 15:30 | COFFEE BREAK (E-POSTER PRESENTATION) |
15:30 - 16:15 |
Abstract Session 4
Chairperson: Pınar Türker Duyuler |
16:15 - 16:30 | COFFEE BREAK (E-POSTER PRESENTATION) |
16:30 - 17:45 |
Abstract Session 5
Chairperson: Yasemin Kılavuz Doğan |
16:30 - 17:45 |
Abstract Session 6
Chairperson: Mesut Demir |
09:15 - 10:15 |
Abstract Session 7
Chairperson: Ebru Akgül Ercan |
10:15 - 10:45 | COFFEE BREAK (E-POSTER PRESENTATION) |
10:30 - 11:30 |
(KVAK & IAYC joint session)
Revisiting Chronic Heart Failure Chairpersons: Oktay Ergene, Larisa Dizdarevic 2023 ACC Expert Consensus on Management of HFpEF: Key Points Yasmin Rustamova Fantastic 5: Ablation in heart failure patients with atrial fibrillation Lorenzo Constantini Interventional new devices for HF patients Behrad Elahi 13:15-13:30 Discussion |
10:45 - 12:00 |
Abstract Session 8
Chairperson: Aycan Fahri Erkan |
12:00 - 12:30 | COFFEE BREAK |
13:30 - 14:30 | LUNCH |
14:30 - 15:45 |
Device and Non-invasive Therapies
Chairpersons: Fethi Kılıçarslan, Ufuk İyigün Treatment of hypertrophic cardiomyopathy arrhythmias Emir Baskovski Contemporary ICD use in patients with heart failure Marta Acena Ramos Clinical effects of enhanced external counterpulsation İlaha Agayeva 15:30-15:45 Discussion |
15:45 - 16:00 | COFFE BREAK |
16:00 - 17:15 |
Acute Heart Failure
Chairpersons: Zumreta Kušljugić , Hamza Duygu Clinical phenotypes and gender-related differences Ümit Yaşar Sinan Value of echocardiography in the treatment of patients with acute heart failure Rezzan Deniz Acar The current and future status of inotropes in heart failure management Sherzod Amedov 17:00-17:15 Discussion |
09:15 - 10:30 |
New breath in heart failure treatment: SGLT2 inhibitors
Chairpersons: Hakan Altay, Lorenzo Constantini Is there a difference between SGLT2 inhibitors in the treatment of heart failure? Aycan Fahri Erkan When should SGLT2 inhibitors be started in the treatment of HFrEF? Mehmet Ali Çetiner Will SGLT2 inhibitors meet the expectations in the treatment of HFpEF? Eleni Nakou 10:15-10:30 Discussion |
10:30 - 11:00 | COFFEE BREAK |
11:00 - 12:15 |
Pulmonary Hypertension
Chairpersons: Berkay Ekici, Mesut Demir Gray Area in Pulmonary Hypertension: PH Due to HFpEF and HFrEF Selvi Öztaş Is there a place for PAH-specific treatments in Group 2 PH? Ebru Akgül Ercan Differentiation between Group 1 and Group 2 PH in the diagnostic approach Çağlar Emre Çağlıyan 12:00-12:15 Discussion |
12:45 - 13:45 |
(KVAK & IAYC joint session)
Advanced Heart Failure Chairpersons: Ahmet Karagöz, Yasmin Rustamova Updated definition and prognostic stratification İlaha Aghaeva Management of Obstructive Sleep Apnea Ahmed Mascdı Mechanical circulatory support devices Arash Hashemi 13:15-13:30 Discussion |
13:30 - 14:30 | LUNCH |
14:30 - 15:45 |
Optimisation of treatments for heart failure with reduced ejection fraction in routine practice
Chairpersons: Mehdi Zoghi, Özlem Yıldırımtürk Who is the team captain? ARNi or SGLT2-i? Rezzan Denir Acar Biomarker-Guided Therapy Larisa Dizdarevic How to diagnose and treat venous congestion? Ebru Akgül Ercan 15:30-15:45 Discussion |
15:45 - 16:00 | COFFEE BREAK |
09:00 - 10:00 |
Abstract Session 9
Chairperson: Berkay Ekici, Javokhır Akhrorov |
10:00 - 11:00 |
Abstract Session 10
Chairperson: Sinem Çakal, Sherzod Ahmedov |
09:00 - 10:00 |
Abstract Session 11
Chairperson: M. Fatih Yılmaz, Selçuk Öztürk |
10:00 - 11:00 |
Abstract Session 12
Chairperson: Behrad Elahi, Mehmet Ali Çetiner |
11:00 - 12:15 |
Abstract Session 13
Chairperson: Yasemin Kılavuz Doğan |
11:00 - 11:10 | CONGRESS CLOSING CEREMONY |
Prof. Dr. Berkay Ekici
[email protected]
GENX KONGRE VE ORGANİZASYON
İcadiye Cad. No:3 Kuzguncuk 34674 İstanbul
+90(216) 310 11 00
+90(216) 310 06 00
[email protected]
www.genx.com.tr